Assessing vaccine-mediated protection in an ultra-low dose Mycobacterium tuberculosis murine model
Plumlee, C. R.; Barrett, H. W.; Shao, D. E.; Lien, K. A.; Cross, L. M.; Cohen, S. B.; Edlefsen, P. T.; Urdahl, K. B.
Show abstract
Despite widespread immunization with Bacille-Calmette-Guerin (BCG), the only currently licensed tuberculosis (TB) vaccine, TB remains a leading cause of mortality globally. There are many TB vaccine candidates in the developmental pipeline, but the lack of a robust animal model to assess vaccine efficacy has hindered our ability to prioritize candidates for human clinical trials. Here we use a murine ultra-low dose (ULD) Mycobacterium tuberculosis (Mtb) challenge model to assess protection conferred by BCG vaccination. We show that BCG confers a reduction in lung bacterial burdens that is more durable than that observed after conventional dose challenge, curbs Mtb dissemination to the contralateral lung, and, in a small percentage of mice, prevents detectable infection. These findings are consistent with the ability of human BCG vaccination to mediate protection, particularly against disseminated disease, in specific human populations and clinical settings. Overall, our findings demonstrate that the ultra-low dose Mtb infection model can measure distinct parameters of immune protection that cannot be assessed in conventional dose murine infection models and could provide an improved platform for TB vaccine testing.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin 95%
- A Second Generation Leishmanization Vaccine with a Markerless Attenuated Leishmania major Strain using CRISPR gene editing 93%
- SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques 92%
Similar papers in this journal
- Antibiotic treatment does not abrogate protection against Mycobacterium tuberculosis reinfection 96%
- Efficient 5-OP-RU-induced enrichment of Mucosal-associated invariant T cells in the murine lung does not enhance control of aerosol Mycobacterium tuberculosis infection. 95%
- Characterizing PET CT patterns and bacterial dissemination features of tuberculosis relapse in the macaque model 94%
Similar papers in this journal
Similar papers in this journal
- In vivo antigen expression regulates CD4 T cell differentiation and vaccine efficacy against Mycobacterium tuberculosis infection 95%
- Lung epithelial signaling mediates early vaccine-induced CD4+ T cell activation and Mtb control 95%
- Acute malaria dysregulates specialized lymph node macrophages to suppress vaccine-elicited protection against Ebola virus 93%
Similar papers in this journal
- Exposure to mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection 94%
- Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis 94%
- Fatty acid metabolism in neutrophils promotes lung damage and bacterial replication during tuberculosis. 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.